Skip to main content
. Author manuscript; available in PMC: 2011 May 25.
Published in final edited form as: Clin Infect Dis. 2010 Mar 1;50(5):779–786. doi: 10.1086/650537

Table 3. Multivariable Analyses: Virologic Failure.

Patient characteristics Derivation Set (MGH, n = 712) Validation Set (BWH, n = 362) z-test*




VF Rate OR 95% CI p-value VF Rate OR 95% CI p-value p-value
Sub-optimal Adherence 20.5% 2.77 1.67, 4.58 <0.0001 23.5% 3.77 1.80, 7.96 0.001 0.499
CD4 count <100/μL 34.5% 2.98 1.20, 7.42 0.019 30.8% 1.22 0.26, 5.62 0.803 0.325
Drug and or Alcohol 17.0% 1.89 1.14, 3.12 0.013 17.4% 1.78 0.80, 3.99 0.159 0.908
Heavily ART experienced 19.8% 2.16 1.29, 3.60 0.003 16.7% 2.00 0.92, 4.34 0.079 0.872
Missed ≥1 Appointment 17.0% 1.72 1.04, 2.85 0.034 14.8% 1.11 0.51, 2.45 0.788 0.361
Prior Virologic Failure 14.8% 6.30 1.88, 21.07 0.003 18.8% 2.61 1.14, 5.95 0.023 0.237
Suppressed <12 months 18.6% 1.80 1.05, 3.10 0.034 19.6% 2.22 1.04, 4.72 0.039 0.662



Hosmer-Lemeshow test χ2 = 6.6, p = 0.58 χ2 = 1.9, p = 0.93
Discrimination c-statistic = 0.78 c-statistic = 0.79
*

z-test - compares the similarity of the two models' beta-coefficients for each predictor